Article
Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose.
Lung cancer (Amsterdam, Netherlands) - 1 Jan 2013
Li Hang, Pan Yunjian, Li Yuan, Li Chenguang, Wang Rui, Hu Haichuan, Zhang Yang, Ye Ting, Wang Lei, Shen Lei, Sun Yihua, Chen Haiquan
Abstract excerpt
PURPOSE: We performed this analysis to reveal the association between six well-identified oncogenic driver mutations and clinical and pathological features in lung adenocarcinomas from smokers. It may have the potentiality to optimize existing treatment strategies and clinical trial design. METHODS: In this series, 230 resected lung adenocarcinomas from smoker (>100 cigarettes in lifetime) at single center...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
